
Zoetis Secures CVMP Positive Opinion for Portela® (relfovetmab) in Treating Osteoarthritis Pain in Cats
Zoetis’ Portela® (relfovetmab) Gains Positive CVMP Opinion for First Long-Acting Anti-NGF Therapy to Relieve Osteoarthritis Pain in Cats Zoetis Inc., a global leader in animal health, announced a major regulatory milestone as the Committee for Veterinary Medicinal Products (CVMP) of…












